| ||
| Will Diet Pill Maker Orexigen Benefit From Vivus' Troubles? Minyanville.com MINYANVILLE ORIGINAL It's been a rough week for diet pill maker Vivus (NASDAQ:VVUS). After disclosing Tuesday that early sales of its new weight-loss drug Qsymia is selling slower than expected and that challenges remain, the shares dropped ... See all stories on this topic » | ||
| Diet Chef explains why November is the perfect time to start losing weight The Herald | HeraldOnline.com EDINBURGH, Scotland — Everyone knows it can be more difficult to stick to a diet during the winter, but Diet Chef believes November is the perfect time for people to start losing weight. Often, people begin their weight loss plans in January as a New ... See all stories on this topic » | ||
| New Startup MyDietitian.com Allows Registered Dietitians to Provide Daily ... Sacramento Bee Each user is assigned their personal Registered Dietitian who will review the user's diet timeline seven days a week and educate him or her on the nutritional aspects of the foods consumed and provide recommendations to help the user reach their ... See all stories on this topic » | ||
| Jennifer Lawrence refuses to diet for film roles Hollywood.com The 22-year-old actress has no plans to lose weight to fit into the Hollywood mould, and admits she was determined to look healthy when she trained to play highly-skilled hunter Katniss Everdeen in The Hunger Games. She tells Elle magazine, "In ... See all stories on this topic » | ||
| ||
| Colon Cancer Survival Worse for Patients With High-Carb Diet Cancer Network Patients with colon cancer whose diet consisted of more carbohydrates, including foods that cause high blood-sugar levels had an increased risk of cancer recurrence and death, a new study shows. According to the study authors, these findings support a ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.

No comments:
Post a Comment